Key facts
- It has raised $2.5M; the latest was Seed Round ($2.5M) in Jan 2026.
- Notable investors include High-Tech Gründerfonds, Bayern Kapital, AgriFoodTech Venture Alliance, MAxL, Startup Elevator — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Twogee Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Twogee Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Twogee Biotech
Manufacturer of tailor-made enzymatic systems and microbial production strains intended for the upcycling of lignocellulosic biomass into industrial precursors. The company's platform leverages advanced genetic engineering, high-throughput enzyme discovery, and optimized fermentation protocols to transform agricultural residues into fermentable sugars and bio-based building blocks, enabling biochemical producers to replace conventional petroleum-derived inputs with sustainable, non-food raw materials while achieving higher process yields and significantly lower carbon footprints across their global manufacturing operations.
- Sector
- Materials and Resources
- HQ
- Martinsried, Germany
- Founded
- 2024
- Employees
- 4
- Website
- twogee-biotech.com/
- Ownership
- Privately Held (backing)
Twogee Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Twogee Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Twogee Biotech in its N-PORT filings yet. We sweep new filings monthly.